Acasti Pharma Inc.
ACST
Kedudukan dalam Saham
#29744
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Harga Saham
$0.4256834
Disegerakkan terakhir: 2023-03-27
Modal Pasaran
$18.99M
Perubahan (1 hari)
3.08%
Perubahan (1 tahun)
-87.02%
Negara
CA
Perdagangan Acasti Pharma Inc. (ACST)
Kategori
Healthcare
EPS untuk Acasti Pharma Inc. (ACST)
EPS setakat June 2026 TTM: $-1.17
Menurut laporan kewangan terkini dan harga saham Acasti Pharma Inc., EPS semasa syarikat (TTM) adalah $-1.17. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $-1.35 penurunan berbanding EPS tahun 2023 iaitu $-5.71.
Sejarah EPS untuk Acasti Pharma Inc. dari 2010 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-1.17 | 48.10% |
| 2025 | $-0.79 | -41.48% |
| 2024 | $-1.35 | -76.36% |
| 2023 | $-5.71 | 256.88% |
| 2022 | $-1.60 | -79.90% |
| 2021 | $-7.96 | -5.01% |
| 2020 | $-8.38 | 73.17% |
| 2019 | $-4.84 | -19.49% |
| 2018 | $-6.01 | -61.25% |
| 2016 | $-15.51 | 224.41% |
| 2015 | $-4.78 | -91.08% |
| 2014 | $-53.58 | 24.03% |
| 2013 | $-43.20 | -8.51% |
| 2012 | $-47.22 | 102.66% |
| 2011 | $-23.30 | -26.64% |
| 2010 | $-31.76 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | -1,580.34% |
US
|
|
| $-7.98 | 582.05% |
US
|
|
| $-5.29 | 352.14% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,470.94% |
NL
|
